Aiforia Technologies Plc, Press Release, December 27, 2023 at 01:00 p.m. EET
The Provincial Health Authority of Catania in Italy has selected Aiforia Technologies Plc as a partner for AI-assisted diagnostics in the anatomic pathology laboratory of Gravina Hospital. The collaboration involves the use of the Aiforia Clinical AI solutions for the analysis of tissue samples from breast and prostate cancer patients, as well as the use of the Aiforia AI model development platform. The total value of the contract is approximately EUR 250 thousand for three years.
The contract is part of an initiative to accelerate the diagnostic workflow and automate the image analysis at the anatomic pathology laboratory of Gravina Hospital. The main provider in this tender is an RTI GPI A.S.P lead consortium, and Aiforia is one of their subcontractors.
“We are excited to announce our second large clinical project in Italy this year. This partnership further enhances our standing in the European clinical pathology market and underscores the acknowledgment that our solutions align with the requirements of clinical pathology laboratories,” says Jukka Tapaninen, CEO of Aiforia.
Certified Adviser
UB Securities Ltd, tel. +358 9 25 380 225
About Aiforia
Aiforia equips pathologists and scientists in preclinical and clinical labs with powerful deep-learning artificial intelligence software for translating images into discoveries, decisions, and diagnoses. The cloud-based Aiforia products and services aim to escalate the efficiency and precision of medical image analysis beyond current capabilities across various fields, from oncology to neuroscience and more. Find out more: www.aiforia.com
Back to all blog posts
